Sequoia Financial Advisors LLC bought a new position in shares of Cabot Co. (NYSE:CBT – Free Report) during the fourth quarter, HoldingsChannel reports. The firm bought 5,526 shares of the specialty chemicals company’s stock, valued at approximately $461,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust raised its stake in shares of Cabot by 176.0% in the 1st quarter. Parkside Financial Bank & Trust now owns 414 shares of the specialty chemicals company’s stock valued at $28,000 after buying an additional 264 shares in the last quarter. Arlington Trust Co LLC acquired a new position in Cabot in the fourth quarter worth about $34,000. Milestone Investment Advisors LLC acquired a new position in Cabot in the third quarter worth about $79,000. Ronald Blue Trust Inc. lifted its stake in Cabot by 460.7% during the third quarter. Ronald Blue Trust Inc. now owns 1,895 shares of the specialty chemicals company’s stock worth $127,000 after purchasing an additional 1,557 shares during the period. Finally, State of Wyoming boosted its holdings in Cabot by 91.2% during the second quarter. State of Wyoming now owns 2,199 shares of the specialty chemicals company’s stock valued at $147,000 after purchasing an additional 1,049 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors.
Cabot Trading Down 0.8 %
Shares of CBT opened at $91.93 on Thursday. The stock has a fifty day moving average price of $87.85 and a two-hundred day moving average price of $79.41. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.30 and a current ratio of 2.04. The company has a market cap of $5.10 billion, a price-to-earnings ratio of 11.94, a PEG ratio of 0.99 and a beta of 1.28. Cabot Co. has a 52-week low of $63.73 and a 52-week high of $98.34.
Insider Transactions at Cabot
In other news, EVP Jeff Ji Zhu sold 55,233 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the sale, the executive vice president now directly owns 97,201 shares of the company’s stock, valued at $7,767,331.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 3.07% of the stock is owned by company insiders.
Analysts Set New Price Targets
CBT has been the subject of several analyst reports. UBS Group downgraded Cabot from a “buy” rating to a “neutral” rating and cut their target price for the stock from $90.00 to $87.00 in a research report on Monday, January 8th. Mizuho began coverage on shares of Cabot in a research note on Wednesday, March 27th. They issued a “buy” rating and a $104.00 target price on the stock. Finally, StockNews.com lowered shares of Cabot from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Cabot has an average rating of “Moderate Buy” and an average target price of $87.67.
Check Out Our Latest Stock Report on Cabot
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Further Reading
- Five stocks we like better than Cabot
- How to Most Effectively Use the MarketBeat Earnings Screener
- United Airlines Soars on Earnings Beat
- What Makes a Stock a Good Dividend Stock?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- The How and Why of Investing in Biotech Stocks
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.